basebybase

🧬🫀 What if the heart has a second mitochondrial pathway for burning carbohydrates—one that bypasses the mitochondrial pyruvate carrier and protects against heart failure? A new study in Nature challenges the conventional model of cardiac energy metabolism by demonstrating that MCT1 transports lactate into cardiac mitochondria, where LDHB converts it into pyruvate and NADH to support respiration. The central discovery: Mitochondrial lactate oxidation provides an alternative pathway for carbohydrate metabolism, sustaining cardiac energetic flexibility during physiological and pathological stress. 🔬 1. Challenging the classical model of cardiac metabolism The traditional model proposes: Glucose → Glycolysis → Cytosolic pyruvate → MPC → Mitochondrial TCA cycle → ATP Lactate is generally thought to require cytosolic conversion into pyruvate before entering mitochondria. However, using cardiomyocyte-specific Mpc1 knockout mice, researchers observed that glucose-derived carbon continued entering the cardiac TCA cycle despite loss of the mitochondrial pyruvate carrier. Surprisingly, glucose-derived labeling of several TCA intermediates actually increased in young MPC1-deficient hearts. This suggested the existence of an alternative mitochondrial carbohydrate-entry pathway. ⚡ 2. MCT1 provides an MPC-independent metabolic route Researchers identified monocarboxylate transporter 1 (MCT1/SLC16A1) as a critical component of this alternative pathway. In MPC1-deficient mice, pharmacological inhibition of MCT1 using AZD3965 abolished the residual glucose-derived carbon contribution to cardiac TCA metabolism. Conversely, deleting MCT1 reduced lactate-derived TCA labeling while largely preserving glucose-derived labeling. These findings reveal functional redundancy between two mitochondrial substrate-entry systems: MPC → Pyruvate transport MCT1 → Lactate transport This redundancy helps explain how the heart maintains carbohydrate oxidation despite disruption of one pathway. 🧬 3. MCT1 and LDHB form a mitochondrial lactate oxidation system The investigators detected MCT1 in the inner mitochondrial membrane of mouse and human cardiomyocytes. They also identified LDHB within the mitochondrial matrix. The proposed mechanism: Lactate → MCT1-mediated mitochondrial import → LDHB-mediated oxidation → Pyruvate + NADH The generated pyruvate can contribute carbon to the TCA cycle, while NADH supplies reducing equivalents for mitochondrial respiration. This arrangement allows lactate oxidation to occur without competing directly with cytosolic glycolysis for NAD⁺. Importantly, the study provides biochemical and functional evidence supporting the long-debated mitochondrial lactate shuttle hypothesis. 🔍 4. Direct evidence from mitochondrial isotope tracing Researchers combined several complementary approaches: • [U-¹³C]glucose tracing • [U-¹³C]lactate tracing • [2-²H]lactate tracing • Rapid mitochondrial isolation using MITO-Tag • Proteinase K protection assays • Isolated mitochondrial respirometry The results demonstrated that MCT1 deficiency impaired mitochondrial lactate entry and reduced lactate-supported oxygen consumption. By contrast, MPC1 deficiency selectively impaired pyruvate-supported respiration while preserving lactate-supported respiration. Experiments using isolated human cardiac mitochondria further supported MCT1-dependent lactate oxidation. 🔥 5. Lactate oxidation can support respiration independently of TCA-cycle carbon oxidation One particularly intriguing observation involved inhibition of pyruvate dehydrogenase and α-ketoglutarate dehydrogenase using CPI-613. Although CPI-613 markedly suppressed lactate-derived citrate labeling, lactate-supported mitochondrial respiration remained largely unchanged. This suggests that LDHB-generated NADH can contribute to respiratory electron transport independently of complete lactate-carbon oxidation through the TCA cycle. The distinction is important: Lactate is both a carbon substrate and a source of reducing equivalents. This expands the conventional understanding of lactate as merely a precursor for mitochondrial acetyl-CoA production. 🫀 6. MCT1 deficiency accelerates stress-induced heart failure Under baseline conditions, cardiomyocyte-specific MCT1 knockout mice maintained relatively normal cardiac function and exercise capacity. However, under pathological stress, the phenotype changed dramatically. Following angiotensin II plus phenylephrine treatment, MCT1-deficient mice developed: • Greater cardiac hypertrophy • Reduced left ventricular ejection fraction • Reduced stroke volume and cardiac output • Increased mortality Similar functional deterioration occurred following transverse aortic constriction. Thus, mitochondrial lactate metabolism appears particularly important when the heart faces increased energetic demand. ⚠️ 7. Loss of MCT1 worsens mitochondrial damage Electron microscopy revealed that MCT1-deficient cardiomyocytes exhibited abnormal mitochondrial morphology and reduced cristae density. Under neurohormonal stress, these abnormalities became more pronounced. MCT1 deficiency was also associated with: • Impaired lactate-derived TCA metabolism • Altered myocardial nucleotide metabolism • Increased mitochondrial oxidative stress • Abnormal mitochondrial calcium handling These findings suggest that MCT1-dependent lactate oxidation contributes to mitochondrial structural integrity and metabolic resilience. 🩸 8. MCT1 protects against ischemia–reperfusion injury In mouse models of myocardial ischemia–reperfusion injury, MCT1 deficiency increased myocardial necrosis. Following injury, control mice recovered systolic function toward baseline. In contrast, MCT1-deficient mice exhibited persistent impairment in left ventricular function during follow-up. These findings identify mitochondrial lactate metabolism as a potential determinant of myocardial recovery after ischemic injury. 🧪 9. Human heart failure samples support biological relevance Researchers examined myocardial samples from non-failing donors and patients with advanced heart failure. MCT1 was detectable in purified human cardiac mitochondria. Interestingly, mitochondrial MCT1 abundance was increased in failing hearts compared with donor controls. This may represent a compensatory response to impaired mitochondrial metabolism. However, whether increased mitochondrial MCT1 is protective, maladaptive, or simply associated with disease progression remains unresolved. 🎯 10. Therapeutic implications The study identifies several potential research directions: Enhancing mitochondrial lactate utilization Could increasing mitochondrial MCT1 activity improve energetic flexibility in stressed cardiomyocytes? Preserving mitochondrial LDHB activity Could optimizing matrix-localized lactate oxidation support NADH production and respiratory function? Targeting metabolic redundancy Could coordinated modulation of MPC and MCT1 improve adaptation to pathological cardiac stress? Reconsidering systemic MCT1 inhibition MCT1 inhibitors are being investigated in oncology. These findings raise questions about potential cardiac consequences, particularly in patients with pre-existing cardiovascular disease. Importantly, the study does not establish a clinically validated MCT1-targeted therapy. ⚠️ 11. Important limitations The causal cardiac injury experiments were predominantly performed in mice. Human evidence supports mitochondrial MCT1 localization and lactate oxidation but does not establish therapeutic efficacy. MCT1 also functions at the plasma membrane, and its mitochondrial and cytosolic transport roles cannot be completely separated in the in vivo knockout experiments. The relative contribution of mitochondrial lactate oxidation to total ATP production under different human physiological conditions remains uncertain. The broader implication Lactate is not merely a glycolytic waste product. It is an important oxidative fuel and redox substrate. This study establishes an MCT1–LDHB-dependent mitochondrial pathway that allows the heart to oxidize lactate independently of the conventional mitochondrial pyruvate carrier. The findings provide a new mechanistic framework for understanding cardiac metabolic flexibility, mitochondrial redox homeostasis, and susceptibility to heart failure. The next challenge is determining whether selective enhancement of mitochondrial lactate metabolism can improve cardiac recovery without disrupting systemic lactate transport. 📄 Cluntun AA, Visker JR, Velasco-Silva JN, Carrington J, et al. MCT1-dependent mitochondrial lactate import sustains cardiac metabolism. Nature. 2026. DOI: doi.org/10.1038/s41586-026-1… #CardiacMetabolism #Mitochondria #Lactate #MCT1 #SLC16A1 #LDHB #MPC1 #HeartFailure #CardiovascularResearch #MetabolicFlexibility #IschemiaReperfusion #MitochondrialMetabolism #PrecisionMedicine Source: Uploaded Nature original research article, particularly Figures 1–4 and Extended Data Figures 1–12. s41586-026-11182-3.pdf s41586-026-11182-3.pdf